Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2009; 54:1660-1673, doi:10.1016/j.jacc.2009.08.012
© 2009 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Soukoulis, V.
Right arrow Articles by Gheorghiade, M.
PubMed
Right arrow Articles by Soukoulis, V.
Right arrow Articles by Gheorghiade, M.
Related Collections
Right arrowRelated Article

QUARTERLY FOCUS ISSUE: HEART FAILURE: VIEWPOINT

Micronutrient Deficiencies

An Unmet Need in Heart Failure

Victor Soukoulis, MD, PhD*, Jamil B. Dihu, DO{ddagger}, Michael Sole, MD§, Stefan D. Anker, MD, PhD||, John Cleland, MD#, Gregg C. Fonarow, MD**, Marco Metra, MD{dagger}{dagger}, Evasio Pasini, MD{ddagger}{ddagger}, Theresa Strzelczyk, APN, CNS*, Heinrich Taegtmeyer, MD, DPhil§§,* and Mihai Gheorghiade, MD{dagger}

* Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois
{dagger} Center for Cardiovascular Quality and Outcomes, Northwestern University Feinberg School of Medicine, Chicago, Illinois
{ddagger} Department of Medicine, University of Chicago (North Shore), Pritzker School of Medicine, Chicago, Illinois
§ Division of Cardiology, University Health Network, Toronto, Ontario, Canada
|| Department of Cardiology, Charite, Campus Virchow-Klinikum, Berlin, Germany
Centre for Clinical and Basic Research, IRCCS San Raffaele, Roma, Italy
# Department of Cardiology, Castle Hill Hospital, Hull York Medical School, Kingston upon Hull, United Kingdom
** Division of Cardiology, David Geffen School of Medicine at UCLA, Los Angeles, California
{dagger}{dagger} Section of Cardiovascular Diseases, Department of Experimental and Applied Sciences, University of Brescia, Brescia, Italy
{ddagger}{ddagger} Fondazione "S Maugeri," Medical Centre of Lumezzane, Brescia, Italy
§§ Department of Medicine/Cardiology, University of Texas Houston Medical School, Houston, Texas

Manuscript received July 16, 2009; revised manuscript received August 24, 2009, accepted August 25, 2009.

* Reprint requests and correspondence: Dr. Heinrich Taegtmeyer, Department of Internal Medicine, Division of Cardiology, University of Texas Houston Medical School, 6431 Fannin, MSB 1.246, Houston, Texas 77030 (Email: Heinrich.Taegtmeyer{at}uth.tmc.edu).

Heart failure (HF) is a common, disabling, and costly disease. Despite major advances in medical therapy, morbidity and mortality remain high, in part because current pharmacological regimens may not fully address some unique requirements of the heart for energy. The heart requires a continuous supply of energy-providing substrates and amino acids in order to maintain its function. In HF, defects in substrate metabolism and cardiac energy and substrate utilization may contribute to contractile dysfunction. HF is often accompanied by a deficiency in key micronutrients required for unimpeded energy transfer. Correcting these deficits has been proposed as a method to limit or even reverse the progressive myocyte dysfunction and/or necrosis in HF. This review summarizes the existing HF literature with respect to supplementation trials of key micronutrients involved in cardiac metabolism: coenzyme Q10, L-carnitine, thiamine, and amino acids, including taurine. Studies using a broader approach to supplementation are also considered. Although some of the results are promising, none are conclusive. There is a need for a prospective trial to examine the effects of micronutrient supplementation on morbidity and mortality in patients with HF.

Key Words: heart failure • nutrition • energy • micronutrients • metabolism

Abbreviations and Acronyms
  ATP = adenosine triphosphate
  CoQ10 = coenzyme Q10
  EF = ejection fraction
  HF = heart failure
  LV = left ventricle/ventricular
  LVEDV = left ventricular end-diastolic volume
  LVESV = left ventricular end-systolic volume
  MRI = magnetic resonance imaging
  NYHA = New York Heart Association


Related Article

Inside This Issue
J. Am. Coll. Cardiol. 2009 54: A26. [Full Text] [PDF]





 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement